203 related articles for article (PubMed ID: 35065983)
1. Predicting Pancreatic Cancer in the UK Biobank Cohort Using Polygenic Risk Scores and Diabetes Mellitus.
Sharma S; Tapper WJ; Collins A; Hamady ZZR
Gastroenterology; 2022 May; 162(6):1665-1674.e2. PubMed ID: 35065983
[TBL] [Abstract][Full Text] [Related]
2. Is diabetes onset at advanced age a sign of pancreatic cancer?
Ozsay O; Karabacak U; Cetin S; Majidova N
Ann Ital Chir; 2022; 93():476-480. PubMed ID: 36156490
[TBL] [Abstract][Full Text] [Related]
3. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
Galeotti AA; Gentiluomo M; Rizzato C; Obazee O; Neoptolemos JP; Pasquali C; Nentwich M; Cavestro GM; Pezzilli R; Greenhalf W; Holleczek B; Schroeder C; Schöttker B; Ivanauskas A; Ginocchi L; Key TJ; Hegyi P; Archibugi L; Darvasi E; Basso D; Sperti C; Bijlsma MF; Palmieri O; Hlavac V; Talar-Wojnarowska R; Mohelnikova-Duchonova B; Hackert T; Vashist Y; Strouhal O; van Laarhoven H; Tavano F; Lovecek M; Dervenis C; Izbéki F; Padoan A; Małecka-Panas E; Maiello E; Vanella G; Capurso G; Izbicki JR; Theodoropoulos GE; Jamroziak K; Katzke V; Kaaks R; Mambrini A; Papanikolaou IS; Szmola R; Szentesi A; Kupcinskas J; Bursi S; Costello E; Boggi U; Milanetto AC; Landi S; Gazouli M; Vodickova L; Soucek P; Gioffreda D; Gemignani F; Brenner H; Strobel O; Büchler M; Vodicka P; Paiella S; Canzian F; Campa D
J Med Genet; 2021 Jun; 58(6):369-377. PubMed ID: 32591343
[TBL] [Abstract][Full Text] [Related]
4. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
Lee S; Hwang HK; Kang CM; Lee WJ
Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
[TBL] [Abstract][Full Text] [Related]
5. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
[TBL] [Abstract][Full Text] [Related]
6. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
[TBL] [Abstract][Full Text] [Related]
7. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.
Chang MC; Chen CH; Liang JD; Tien YW; Hsu C; Wong JM; Chang YT
World J Gastroenterol; 2014 May; 20(17):5060-5. PubMed ID: 24803819
[TBL] [Abstract][Full Text] [Related]
9. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
10. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population.
Bogumil D; Conti DV; Sheng X; Xia L; Shu XO; Pandol SJ; Blot WJ; Zheng W; Le Marchand L; Haiman CA; Setiawan VW
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2686-2692. PubMed ID: 32958499
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive Models Screen New-Onset Diabetics at Low Risk of Early-Onset Pancreatic Cancer.
Khan S; Al Heraki S; Kupec JT
Pancreas; 2021 Oct; 50(9):1326-1330. PubMed ID: 34860819
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
[TBL] [Abstract][Full Text] [Related]
14. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
Illés D; Ivány E; Holzinger G; Kosár K; Adam MG; Kamlage B; Zsóri G; Tajti M; Svébis MM; Horváth V; Oláh I; Márta K; Váncsa S; Zádori N; Szentesi A; Czakó B; Hegyi P; Czakó L
BMJ Open; 2020 Nov; 10(11):e037267. PubMed ID: 33444177
[TBL] [Abstract][Full Text] [Related]
15. Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study.
Lee HS; Chae W; Sung MJ; Keum J; Jo JH; Chung MJ; Park JY; Park SW; Song SY; Park EC; Nam CM; Jang SI; Bang S
J Clin Endocrinol Metab; 2023 May; 108(6):1338-1347. PubMed ID: 36548964
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
[TBL] [Abstract][Full Text] [Related]
17. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
[TBL] [Abstract][Full Text] [Related]
18. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.
Balasenthil S; Huang Y; Liu S; Marsh T; Chen J; Stass SA; KuKuruga D; Brand R; Chen N; Frazier ML; Jack Lee J; Srivastava S; Sen S; McNeill Killary A
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376184
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank.
Jacobs BM; Belete D; Bestwick J; Blauwendraat C; Bandres-Ciga S; Heilbron K; Dobson R; Nalls MA; Singleton A; Hardy J; Giovannoni G; Lees AJ; Schrag AE; Noyce AJ
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1046-1054. PubMed ID: 32934108
[TBL] [Abstract][Full Text] [Related]
20. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
Gomez-Rubio P; Rosato V; Márquez M; Bosetti C; Molina-Montes E; Rava M; Piñero J; Michalski CW; Farré A; Molero X; Löhr M; Ilzarbe L; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Domínguez-Muñoz E; Gutiérrez-Sacristán A; Balsells J; Costello E; Guillén-Ponce C; Huang J; Iglesias M; Kleeff J; Kong B; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Lawlor RT; Carrato A; Hidalgo M; Scarpa A; Sharp L; Furlong LI; Real FX; La Vecchia C; Malats N;
Ann Oncol; 2017 Jul; 28(7):1618-1624. PubMed ID: 28383714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
